“Risk-Based” Enforcement Approach to Homeopathic Products Will Be Taken By Federal Regulators
The FDA has announced it will take a "risk-based" approach to enforcement of homeopathic products.
The FDA has announced it will take a "risk-based" approach to enforcement of homeopathic products.
The FDA has issued warning letters to four companies making injectable homeopathic drugs, saying they are unapproved products made with poor manufacturing standards.
The FDA has issued new guidance and made policy changes altering its enforcement of homeopathic products to focus on those with the highest risk to the public.
The FDA announced it has sent warning letters to the makers of homeopathic Puriton Eye Relief Drops, saying their manufacturing processes may make their products unsterile and unsafe to use.
The FDA is warning homeopathic drug manufacturers about the use of poor manufacturing processes and contamination.
The FDA has proposed new guidelines for addressing safety concerns linked to unproven and potentially dangerous homeopathic products.
Varying levels of belladonna have been found in several CVS homeopathic children's products for teething and earaches, resulting in a nationwide recall.
The FDA is warning parents that homeopathic teething tablets and gels should not be given to infants, warning that there could be health risks.
The FDA is considering new regulations on how homeopathic remedies are reviewed and sold following several safety recalls in recent years.
The FDA is warning consumers not to use homeopathic drugs to treat asthma, as they may not work and could put their lives in danger.